| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma, Cavernous, Central Nervous System | 61 | 2026 | 278 | 9.560 |
Why?
|
| Hemorrhage | 24 | 2023 | 299 | 1.810 |
Why?
|
| rho-Associated Kinases | 11 | 2019 | 162 | 1.670 |
Why?
|
| Brain Neoplasms | 11 | 2022 | 839 | 1.450 |
Why?
|
| Cerebral Hemorrhage | 12 | 2025 | 377 | 1.390 |
Why?
|
| Hemangioma, Cavernous | 8 | 2021 | 66 | 1.260 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2021 | 201 | 1.200 |
Why?
|
| Disease Models, Animal | 18 | 2026 | 2572 | 0.970 |
Why?
|
| Intracranial Arteriovenous Malformations | 8 | 2011 | 147 | 0.930 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 403 | 0.910 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 6 | 2020 | 36 | 0.890 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2025 | 3606 | 0.890 |
Why?
|
| Central Nervous System Neoplasms | 5 | 2019 | 104 | 0.860 |
Why?
|
| NF-kappa B | 14 | 2003 | 423 | 0.840 |
Why?
|
| Proto-Oncogene Proteins | 14 | 2021 | 682 | 0.790 |
Why?
|
| Lung | 19 | 2023 | 1407 | 0.780 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 138 | 0.730 |
Why?
|
| Endothelial Cells | 16 | 2026 | 500 | 0.700 |
Why?
|
| Mice | 47 | 2026 | 12698 | 0.690 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 4 | 2026 | 83 | 0.640 |
Why?
|
| KRIT1 Protein | 14 | 2022 | 62 | 0.640 |
Why?
|
| Simvastatin | 2 | 2019 | 106 | 0.620 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2001 | 64 | 0.610 |
Why?
|
| Biomarkers | 17 | 2025 | 2020 | 0.590 |
Why?
|
| Endotoxemia | 6 | 2001 | 19 | 0.580 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 642 | 0.570 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2026 | 403 | 0.570 |
Why?
|
| Animals | 56 | 2026 | 28894 | 0.540 |
Why?
|
| Capillary Permeability | 6 | 2021 | 133 | 0.510 |
Why?
|
| Membrane Proteins | 6 | 2021 | 1285 | 0.510 |
Why?
|
| Kruppel-Like Transcription Factors | 5 | 2026 | 118 | 0.450 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2026 | 285 | 0.440 |
Why?
|
| Mutation | 12 | 2021 | 4392 | 0.440 |
Why?
|
| Sirolimus | 3 | 2024 | 182 | 0.410 |
Why?
|
| Male | 60 | 2026 | 47076 | 0.410 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 3 | 2026 | 15 | 0.400 |
Why?
|
| Microtubule-Associated Proteins | 9 | 2022 | 186 | 0.400 |
Why?
|
| Cytokines | 7 | 2017 | 889 | 0.390 |
Why?
|
| Humans | 68 | 2026 | 98080 | 0.390 |
Why?
|
| Propranolol | 3 | 2022 | 43 | 0.380 |
Why?
|
| Neutrophil Activation | 4 | 2002 | 11 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 16 | 2002 | 1110 | 0.330 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 640 | 0.320 |
Why?
|
| Adult | 27 | 2026 | 29539 | 0.320 |
Why?
|
| Brain | 10 | 2020 | 2430 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2024 | 400 | 0.310 |
Why?
|
| Carrier Proteins | 6 | 2019 | 667 | 0.300 |
Why?
|
| Female | 40 | 2026 | 51536 | 0.290 |
Why?
|
| Signal Transduction | 7 | 2026 | 3620 | 0.290 |
Why?
|
| Transcriptome | 5 | 2024 | 820 | 0.280 |
Why?
|
| MicroRNAs | 2 | 2025 | 604 | 0.280 |
Why?
|
| Mice, Knockout | 9 | 2024 | 2207 | 0.280 |
Why?
|
| Neutrophils | 6 | 2002 | 346 | 0.280 |
Why?
|
| Prospective Studies | 11 | 2025 | 4823 | 0.270 |
Why?
|
| Iron | 4 | 2018 | 178 | 0.270 |
Why?
|
| Resuscitation | 5 | 1995 | 144 | 0.270 |
Why?
|
| Machine Learning | 4 | 2025 | 408 | 0.260 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 1604 | 0.260 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 108 | 0.250 |
Why?
|
| Lipopolysaccharides | 6 | 2020 | 313 | 0.250 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2023 | 57 | 0.250 |
Why?
|
| Young Adult | 13 | 2025 | 7507 | 0.250 |
Why?
|
| Middle Aged | 25 | 2026 | 29428 | 0.240 |
Why?
|
| Receptor, TIE-2 | 1 | 2026 | 20 | 0.240 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2023 | 16 | 0.230 |
Why?
|
| Macrophages, Alveolar | 5 | 2000 | 67 | 0.220 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2024 | 9 | 0.210 |
Why?
|
| Chemokine CX3CL1 | 1 | 2024 | 6 | 0.210 |
Why?
|
| B-Lymphocytes | 5 | 2018 | 727 | 0.210 |
Why?
|
| Proof of Concept Study | 2 | 2025 | 63 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 1302 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 4 | 2024 | 356 | 0.200 |
Why?
|
| RNA, Messenger | 13 | 2021 | 2063 | 0.200 |
Why?
|
| Adolescent | 12 | 2025 | 10080 | 0.200 |
Why?
|
| Astrocytes | 2 | 2021 | 142 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2003 | 707 | 0.200 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2022 | 75 | 0.190 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 164 | 0.190 |
Why?
|
| Disease Progression | 4 | 2021 | 1610 | 0.190 |
Why?
|
| Gene Expression | 4 | 2003 | 1320 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2020 | 661 | 0.190 |
Why?
|
| Cohort Studies | 8 | 2025 | 3212 | 0.190 |
Why?
|
| Plasma Cells | 3 | 2020 | 89 | 0.180 |
Why?
|
| Child, Preschool | 7 | 2020 | 4001 | 0.180 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 55 | 0.180 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 14 | 0.180 |
Why?
|
| Catecholamines | 2 | 1999 | 94 | 0.170 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2021 | 7 | 0.170 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 211 | 0.160 |
Why?
|
| ADAMTS5 Protein | 1 | 2020 | 4 | 0.160 |
Why?
|
| Versicans | 1 | 2020 | 7 | 0.160 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 52 | 0.160 |
Why?
|
| Gene Deletion | 3 | 2020 | 353 | 0.160 |
Why?
|
| Child | 8 | 2020 | 7681 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 895 | 0.160 |
Why?
|
| Brain Stem | 1 | 2021 | 167 | 0.160 |
Why?
|
| Microbiota | 1 | 2026 | 467 | 0.160 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 663 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 3598 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2019 | 95 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 218 | 0.150 |
Why?
|
| Xanthine Oxidase | 4 | 2001 | 25 | 0.150 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 75 | 0.150 |
Why?
|
| Follow-Up Studies | 6 | 2026 | 4025 | 0.150 |
Why?
|
| Autoantigens | 1 | 2020 | 145 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 750 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2020 | 286 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2001 | 447 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 239 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 1996 | 136 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1129 | 0.130 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 22 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 198 | 0.130 |
Why?
|
| Stroke | 3 | 2023 | 1154 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 1945 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 1999 | 525 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2017 | 2855 | 0.120 |
Why?
|
| Permeability | 3 | 2021 | 145 | 0.120 |
Why?
|
| Temporal Arteries | 2 | 2009 | 10 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 1996 | 211 | 0.120 |
Why?
|
| Endothelium, Vascular | 4 | 2020 | 440 | 0.110 |
Why?
|
| Bayes Theorem | 3 | 2022 | 422 | 0.110 |
Why?
|
| Aged | 11 | 2025 | 21758 | 0.110 |
Why?
|
| Double-Blind Method | 3 | 2025 | 1782 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2019 | 90 | 0.110 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 173 | 0.110 |
Why?
|
| Pregnatrienes | 1 | 1995 | 14 | 0.110 |
Why?
|
| P-Selectin | 1 | 1995 | 14 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2017 | 373 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1284 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2009 | 2555 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 212 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 77 | 0.110 |
Why?
|
| Genes, MHC Class II | 2 | 1993 | 28 | 0.110 |
Why?
|
| Keratin-1 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Seizures | 1 | 2017 | 318 | 0.110 |
Why?
|
| Stress Fibers | 1 | 2014 | 24 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 461 | 0.100 |
Why?
|
| Peyer's Patches | 1 | 1994 | 19 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 89 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1565 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 642 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2026 | 9711 | 0.100 |
Why?
|
| Contrast Media | 4 | 2021 | 1011 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2025 | 977 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 1416 | 0.100 |
Why?
|
| Vitamin D | 1 | 2016 | 286 | 0.100 |
Why?
|
| Antioxidants | 1 | 1995 | 236 | 0.100 |
Why?
|
| Infant | 2 | 2014 | 3328 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2017 | 481 | 0.100 |
Why?
|
| Recombination, Genetic | 2 | 1993 | 423 | 0.090 |
Why?
|
| Chemokine CXCL2 | 3 | 2001 | 16 | 0.090 |
Why?
|
| Acute Disease | 3 | 2020 | 860 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 356 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 217 | 0.090 |
Why?
|
| Deoxyribonuclease I | 1 | 1991 | 27 | 0.080 |
Why?
|
| Base Sequence | 9 | 2005 | 2222 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 134 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2020 | 985 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2784 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2001 | 679 | 0.080 |
Why?
|
| Genotype | 4 | 2021 | 1888 | 0.080 |
Why?
|
| Time Factors | 4 | 2026 | 5567 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2001 | 30 | 0.080 |
Why?
|
| Inflammation | 4 | 2011 | 1120 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 2023 | 0.080 |
Why?
|
| Perfusion | 2 | 2021 | 271 | 0.080 |
Why?
|
| Transcription Factors | 4 | 2000 | 1717 | 0.070 |
Why?
|
| Observer Variation | 3 | 2016 | 579 | 0.070 |
Why?
|
| Interferon-gamma | 3 | 1996 | 479 | 0.070 |
Why?
|
| Phenotype | 4 | 2020 | 2638 | 0.070 |
Why?
|
| Ethers | 1 | 2008 | 13 | 0.070 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 42 | 0.070 |
Why?
|
| I-kappa B Proteins | 2 | 2000 | 47 | 0.070 |
Why?
|
| Microdissection | 1 | 2008 | 17 | 0.070 |
Why?
|
| Medical Illustration | 1 | 2008 | 14 | 0.070 |
Why?
|
| Magnetics | 1 | 2008 | 39 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 237 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2008 | 72 | 0.070 |
Why?
|
| Lasers | 1 | 2008 | 105 | 0.070 |
Why?
|
| Fluorocarbons | 1 | 2008 | 64 | 0.070 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 80 | 0.070 |
Why?
|
| Oligoclonal Bands | 1 | 2007 | 3 | 0.070 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2018 | 23 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2021 | 524 | 0.060 |
Why?
|
| Myocardium | 2 | 2003 | 578 | 0.060 |
Why?
|
| Cell Movement | 3 | 1999 | 814 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 480 | 0.060 |
Why?
|
| Endotoxins | 2 | 1999 | 36 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2020 | 721 | 0.060 |
Why?
|
| Intracranial Aneurysm | 1 | 2009 | 239 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1986 | 22 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2026 | 82 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 2896 | 0.060 |
Why?
|
| Interleukin-1 | 3 | 2000 | 72 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 700 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 3334 | 0.060 |
Why?
|
| Moyamoya Disease | 1 | 2025 | 25 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 70 | 0.050 |
Why?
|
| Laminin | 1 | 2005 | 89 | 0.050 |
Why?
|
| DNA Repair | 2 | 1986 | 363 | 0.050 |
Why?
|
| Transcription Factor RelA | 2 | 2001 | 39 | 0.050 |
Why?
|
| Fibronectins | 1 | 2005 | 104 | 0.050 |
Why?
|
| Myosins | 1 | 2005 | 89 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1790 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1995 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 2001 | 102 | 0.050 |
Why?
|
| Chemokines | 2 | 2001 | 79 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 630 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2005 | 131 | 0.050 |
Why?
|
| Interleukins | 2 | 1995 | 135 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 225 | 0.050 |
Why?
|
| Phentolamine | 2 | 2001 | 8 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 1133 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 139 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 1327 | 0.050 |
Why?
|
| Collagen | 1 | 2005 | 313 | 0.050 |
Why?
|
| Peroxidase | 2 | 2000 | 54 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2022 | 36 | 0.050 |
Why?
|
| Aging | 2 | 2020 | 770 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2003 | 58 | 0.050 |
Why?
|
| Genomics | 1 | 2009 | 898 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 81 | 0.050 |
Why?
|
| Recurrence | 1 | 2026 | 1254 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1815 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 128 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 142 | 0.040 |
Why?
|
| Temporal Lobe | 1 | 2003 | 188 | 0.040 |
Why?
|
| CREB-Binding Protein | 1 | 2001 | 16 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 480 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2009 | 380 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 7389 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 402 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 66 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 18 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2003 | 529 | 0.040 |
Why?
|
| Cell Line | 3 | 1996 | 2483 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2011 | 33 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 102 | 0.040 |
Why?
|
| Tungsten | 1 | 2001 | 6 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 84 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 49 | 0.040 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2001 | 18 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 231 | 0.040 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 24 | 0.040 |
Why?
|
| Animal Feed | 1 | 2001 | 22 | 0.040 |
Why?
|
| ADAMTS4 Protein | 1 | 2020 | 4 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 68 | 0.040 |
Why?
|
| ADAMTS1 Protein | 1 | 2020 | 5 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 39 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 41 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 77 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 53 | 0.040 |
Why?
|
| Patient Participation | 1 | 2023 | 246 | 0.040 |
Why?
|
| Hemoptysis | 1 | 2000 | 26 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2020 | 146 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 32 | 0.040 |
Why?
|
| Cholecalciferol | 1 | 2020 | 37 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 49 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 100 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2003 | 743 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 47 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 111 | 0.040 |
Why?
|
| Spin Labels | 1 | 2020 | 107 | 0.040 |
Why?
|
| Tubulin | 1 | 2020 | 61 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 176 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 129 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 286 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2019 | 71 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 92 | 0.040 |
Why?
|
| Monokines | 1 | 1999 | 2 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 355 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 100 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2021 | 159 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 220 | 0.040 |
Why?
|
| Protein Binding | 2 | 2016 | 1554 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 106 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 236 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 304 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 199 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 617 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 270 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 726 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1999 | 30 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 310 | 0.040 |
Why?
|
| Hypoxia | 1 | 2024 | 699 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1384 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 271 | 0.040 |
Why?
|
| Occludin | 1 | 2018 | 66 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 486 | 0.030 |
Why?
|
| Zebrafish | 1 | 2021 | 353 | 0.030 |
Why?
|
| Ischemia | 1 | 2000 | 262 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 387 | 0.030 |
Why?
|
| DNA Replication | 4 | 1986 | 169 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 92 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2021 | 411 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2019 | 318 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 674 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 48 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 340 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 377 | 0.030 |
Why?
|
| Methylation | 2 | 1991 | 294 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 38 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 212 | 0.030 |
Why?
|
| Germ-Free Life | 1 | 2017 | 88 | 0.030 |
Why?
|
| Intestines | 1 | 2020 | 441 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2000 | 1255 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 291 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 282 | 0.030 |
Why?
|
| Colitis | 1 | 2019 | 264 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 492 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 337 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1996 | 38 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 801 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2016 | 33 | 0.030 |
Why?
|
| Cerebellum | 1 | 2018 | 253 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1996 | 11 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 36 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 388 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2016 | 11 | 0.030 |
Why?
|
| Catalase | 1 | 1996 | 46 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 38 | 0.030 |
Why?
|
| Clone Cells | 1 | 1996 | 220 | 0.030 |
Why?
|
| Iodine | 1 | 2016 | 43 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 401 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 226 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 402 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 794 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 709 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1996 | 155 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 668 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 370 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 193 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 1995 | 4 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 889 | 0.030 |
Why?
|
| Spleen | 1 | 1996 | 375 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1123 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 208 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1895 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 212 | 0.030 |
Why?
|
| Risk Factors | 1 | 2026 | 6233 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 834 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
| Models, Biological | 2 | 2020 | 1807 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 21 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 9 | 0.030 |
Why?
|
| Meiosis | 2 | 1993 | 87 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1994 | 94 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2585 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 124 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1994 | 213 | 0.020 |
Why?
|
| Gadolinium | 1 | 2013 | 95 | 0.020 |
Why?
|
| Monocytes | 1 | 1994 | 219 | 0.020 |
Why?
|
| Apoptosis | 1 | 1999 | 1752 | 0.020 |
Why?
|
| Pneumonia | 1 | 1994 | 195 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4116 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2014 | 484 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2010 | 1145 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 313 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 882 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 119 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1764 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2015 | 416 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1996 | 1005 | 0.020 |
Why?
|
| Breeding | 1 | 2010 | 43 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2013 | 570 | 0.020 |
Why?
|
| Testis | 1 | 1991 | 150 | 0.020 |
Why?
|
| Genes | 1 | 1991 | 256 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 298 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 69 | 0.020 |
Why?
|
| Edema, Cardiac | 1 | 2010 | 4 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2010 | 25 | 0.020 |
Why?
|
| Animal Structures | 1 | 2010 | 31 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 301 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 56 | 0.020 |
Why?
|
| Brain Edema | 1 | 2010 | 55 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 58 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2000 | 38 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 94 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 187 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1159 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 564 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 106 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 548 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 715 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 1986 | 233 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 31 | 0.010 |
Why?
|
| Kinetics | 2 | 1986 | 1476 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 55 | 0.010 |
Why?
|
| Cell Nucleus | 2 | 2000 | 615 | 0.010 |
Why?
|
| DNA Polymerase I | 1 | 1986 | 9 | 0.010 |
Why?
|
| Mitosis | 1 | 1986 | 152 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1255 | 0.010 |
Why?
|
| Macrophages | 1 | 2009 | 643 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 308 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 471 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 196 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 451 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1986 | 572 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 4071 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 161 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2000 | 2013 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 1986 | 652 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 1159 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2005 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 911 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 269 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 595 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2000 | 1 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 211 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 27 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 370 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2000 | 38 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2000 | 133 | 0.010 |
Why?
|
| DNA | 1 | 1985 | 1274 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 276 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 148 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1997 | 14 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1997 | 62 | 0.010 |
Why?
|
| Allopurinol | 1 | 1997 | 77 | 0.010 |
Why?
|
| Templates, Genetic | 2 | 1985 | 31 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 293 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 7 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 39 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 474 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1985 | 95 | 0.010 |
Why?
|
| Heart | 1 | 1997 | 527 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1995 | 57 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1995 | 419 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 370 | 0.010 |
Why?
|
| Plasmids | 1 | 1993 | 275 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 1028 | 0.010 |
Why?
|
| Transfection | 1 | 1993 | 883 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1993 | 767 | 0.000 |
Why?
|
| Larva | 1 | 1986 | 139 | 0.000 |
Why?
|
| Sulfuric Acid Esters | 1 | 1985 | 4 | 0.000 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1985 | 16 | 0.000 |
Why?
|
| Alkylating Agents | 1 | 1985 | 32 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 352 | 0.000 |
Why?
|
| Adenine | 1 | 1985 | 101 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1985 | 945 | 0.000 |
Why?
|